These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9198165)

  • 1. Activation of ADP receptors and platelet function.
    Gachet C; Hechler B; Léon C; Vial C; Leray C; Ohlmann P; Cazenave JP
    Thromb Haemost; 1997 Jul; 78(1):271-5. PubMed ID: 9198165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of purine nucleotides on purinergic P2 platelet receptors by small angle light scattering].
    Sakaev MR; Mindukshev IV; Lesiovskaia EE; Petrishchev NN; Krivchenko AI
    Eksp Klin Farmakol; 2000; 63(3):65-9. PubMed ID: 10934601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid resensitization of purinergic receptor function in human platelets.
    Mundell SJ; Barton JF; Mayo-Martin MB; Hardy AR; Poole AW
    J Thromb Haemost; 2008 Aug; 6(8):1393-404. PubMed ID: 18513210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet purinergic sensitivity in peripheral arterial disease--a pilot study.
    Braun OO; Jagroop A; Wang L; Mikhailidis DP; Burnstock G; Erlinge D
    Platelets; 2005 Aug; 16(5):261-7. PubMed ID: 16011976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cangrelor attenuates coated-platelet formation.
    Norgard NB; Hann CL; Dale GL
    Clin Appl Thromb Hemost; 2009; 15(2):177-82. PubMed ID: 18796456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities.
    Frelinger AL; Jakubowski JA; Li Y; Barnard MR; Linden MD; Tarnow I; Fox ML; Sugidachi A; Winters KJ; Furman MI; Michelson AD
    J Thromb Haemost; 2008 Feb; 6(2):359-65. PubMed ID: 18021304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.
    Norgard NB; Saya S; Hann CL; Hennebry TA; Schechter E; Dale GL
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):536-9. PubMed ID: 19034031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
    Mateos-Trigos G; Evans RJ; Heath MF
    Platelets; 2002; 13(5-6):285-92. PubMed ID: 12189014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP and platelets: the end of the beginning.
    Woulfe D; Yang J; Brass L
    J Clin Invest; 2001 Jun; 107(12):1503-5. PubMed ID: 11413156
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory action of glucosamine on platelet activation in guinea pigs.
    Lu-Suguro JF; Hua J; Sakamoto K; Nagaoka I
    Inflamm Res; 2005 Dec; 54(12):493-9. PubMed ID: 16389570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of species differences in the platelet ADP and thrombin response.
    Nylander S; Mattsson C; Lindahl TL
    Thromb Res; 2006; 117(5):543-9. PubMed ID: 15921723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP receptors of platelets and their inhibition.
    Gachet C
    Thromb Haemost; 2001 Jul; 86(1):222-32. PubMed ID: 11487010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 17. Can the PFA-100 be modified to detect P2Y12 inhibition?
    Pidcock M; Harrison P
    J Thromb Haemost; 2006 Jun; 4(6):1424-6. PubMed ID: 16706997
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation.
    Quinton TM; Kim S; Jin J; Kunapuli SP
    J Thromb Haemost; 2005 May; 3(5):1036-41. PubMed ID: 15869601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation.
    Kamae T; Shiraga M; Kashiwagi H; Kato H; Tadokoro S; Kurata Y; Tomiyama Y; Kanakura Y
    J Thromb Haemost; 2006 Jun; 4(6):1379-87. PubMed ID: 16706985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.